Powering Health from within
MitoGenix Therapeutics
MitoGenix Therapeutics LLC stands as a leading biotech startup company, uniquely positioned to advance mitochondrial therapeutic research.
Our specialized focus encompasses chronic inflammation, cancer, neurological disorders, metabolic diseases, and military health applications like Traumatic Brain Injury and Post-Traumatic Stress Disorder
Competitors offer fragments, we offer end-to-end solution via integration of proprietary GM-Mito sequencing for mitochondrial RNA and DNA targets, optimized mitochondrial reprogramming transfer models, and predictive ML capabilities
Mission: To accelerate mitochondrial dysfunction genetic and therapeutic research by providing researchers with high-quality, pre-engineered genetically modified mitochondria in human and murine cell lines and robust in vitro models for mitochondrial transfer and reprogramming, thereby saving time, reducing effort, and enhancing efficiency.
Vision: To be the global leader in providing innovative and reliable tools for mitochondrial research, enabling breakthroughs in understanding and treating mitochondrial diseases and age-related disorders.
Values: Innovation, collaboration, integrity, accountability, and respect
Mitigate R&D Bottlenecks for Mitochondrial Therapies
We provide robust, pre-validated mitochondrial transfer models and datasets, delivering a documented 40–60% reduction in model development time and accelerating your pipeline progression to IND
Validated, Ready-to-Use Systems
Access proprietary, off-the-shelf, genetically modified mitochondria and optimized cell lines, bypassing months of preliminary validation work required for novel mitochondrial reprogramming studies.
Unlocking Cellular Reprogramming via Patented Mitochondria Transfer
Gain exclusive access to patent-pending datasets and validated tools focused on the direct transfer of healthy mitochondria, providing a unique, disease-modifying strategy unavailable through standard genetic approaches
Data-Driven Predictive Power via ML
Leverage our cutting-edge ML platform, which is continually trained by client data, to generate highly accurate predictions of mitochondrial genetic transfer efficacy and subsequent cell reprogramming outcomes, maximizing research success rates.
Strategic Focus on High-Impact Therapeutic Areas
Our tools provide novel mechanistic solutions for complex chronic diseases, including Neurodegeneration, Metabolic Disorders, Oncology, and critical Military Health applications, ensuring broad relevance across your research portfolio
Regulatory Advantage in Rare and Orphan Disease
Our systems are specifically designed to generate data supporting clinical development in areas (including orphan/rare diseases) that qualify for expedited regulatory pathways, helping to de-risk and accelerate your time to market
Our Team
Roberto Ivan Mota Alvidrez, MD, MS, FAHA
rmotaalvidrez@mitogenixtherapeuticsllc.com
Itzel Nahomi Perez Reyes, MD
inperez@mitogenixtherapeuticsllc.com
Join Our Team
〰️
Join Our Team 〰️
Our Promise
Documented 40–60% reduction in model development time
Validated, Ready-to-Use Systems
Proprietary Mechanism & Deep Mechanistic Insight
Broad Application & Strategic De-Risking
ML platform enhances hypothesis generation and experimental validation
Accelerating timelines to IND; De-risking novel drug targets, particularly in complex/orphan diseases; Seeking mechanisms (like mitochondrial transfer) with high therapeutic potential
Our Services
-
Our flagship offering consists of human and murine cell lines containing genetically modified mitochondria for RNA and DNA genetic pathway analysis and reprogramming prediction
-
Developed and validated robust in vitro models that simulate and facilitate mitochondrial transfer
-
Specialized assays to assess the functional impact of transferred mitochondria on recipient cell metabolism, gene expression, and phenotype
-
Tailored genetic modifications to mitochondria based on specific client research requirements
-
Proprietary cutting-edge ML platform, which is continually trained by client data, to generate highly accurate predictions of mitochondrial genetic transfer efficacy and subsequent cell reprogramming outcomes, maximizing research success rates.
Support our efforts
⁎
Support our efforts ⁎
Contact Us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!
Affiliate Disclosures: As an Amazon Associate we might earn from qualifying purchases at no extra cost to you. We might receive a small commission for purchases made through links in this post that help support our efforts. however, there is no direct influence on reviews or customer use. The products exhibited are not directly endorsed by MitoGenix Therapeutics LLC. MitoGenix Therapeutics LLC participates in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com. For more information visit or Privacy Notice.